<DOC>
	<DOCNO>NCT01687426</DOCNO>
	<brief_summary>The purpose study determine intraocular Pressure ( IOP ) lower response evaluate safety brimonidine tartrate 0.025 % ophthalmic solution adult subject open angle glaucoma ocular hypertension .</brief_summary>
	<brief_title>Study Evaluating Safety Intraocular Pressure ( IOP ) Lowering Response Brimonidine Tartrate Ophthalmic Solution Subjects With Open Angle Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Be least 18 year age Visit 1 ( Screening ) , either sex race Be willing able provide write informed consent prior study procedure perform . Be willing able follow instruction attend study visit . Be willing discontinue use disallow medication Have document diagnosis ocular hypertension , open angle glaucoma chronic angle closure glaucoma patent iridotomy . Have know sensitivity poor tolerance brimonidine component study medication . Have form glaucoma openangle glaucoma , ocular hypertension chronic angle closure glaucoma patent iridotomy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>